[1]尚鸣异,张岩,高晓龙,等.多烯紫杉醇对人胆管癌细胞和胰腺癌细胞增殖和凋亡的影响[J].介入放射学杂志,2010,(01):46.
 SHANG Mingyi,ZHANG Yan,GAO Xiaolong,et al.The effect of docetaxel on the proliferation and apoptosis of human cholangiocarcinoma cell line and pancreatic cancer cell line[J].journal interventional radiology,2010,(01):46.
点击复制

多烯紫杉醇对人胆管癌细胞和胰腺癌细胞增殖和凋亡的影响()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2010年01期
页码:
46
栏目:
实验研究
出版日期:
2010-01-15

文章信息/Info

Title:
The effect of docetaxel on the proliferation and apoptosis of human cholangiocarcinoma cell line and pancreatic cancer cell line
作者:
尚鸣异张岩高晓龙唐俊军席芊黄宗良胡美玉王培军
200065上海同济大学附属同济医院放射科(尚鸣异、张岩、高晓龙、唐俊军、席芊、黄宗良);复旦大学附属中山医院中心实验室(胡美玉)
Author(s):
SHANG Ming-yiZHANG YanGAO Xiao-longTANG Jun-junXI QianHUANG Zong-liangHU Mei-yuWANG Pei-jun.
Tongji Hospital,Tongji University,Shanghai200065,China
关键词:
胰腺癌胆管细胞癌多烯紫杉醇增殖凋亡
分类号:
R735.8;R735.9
文献标志码:
B
摘要:
目的评价多烯紫杉醇对人胆管癌细胞HCCC-9810和胰腺癌细胞BXPC-3的增殖和凋亡影响,为药物涂层支架治疗恶性梗阻性黄疸的应用提供实验基础。方法应用四硝基偶氮唑蓝法测定紫杉醇对人胆管癌细胞HCCC-9810和胰腺癌细胞BXPC-3增殖的抑制作用,Hoechst染色法检测诱导细胞凋亡。结果多烯紫杉醇可明显抑制2种肿瘤细胞株的增殖,且该抑制效应随药物剂量的增加和作用时间的延长而增强(HCCC:χ 2 =24.42,P<0.01;BXPC-3:χ 2 =24.68,P<0.01),根据增殖曲线和统计学分析,选取0.4mg /L为多烯紫杉醇最适实验浓度。凋亡分析实验显示多烯紫杉醇可诱导2种肿瘤细胞株的凋亡(HCCC:χ 2 =30.05,P<0.01;BXPC-3:χ 2 =25.22,P<0.01)。结论多烯紫杉醇有抑制BXPC-3和HCCC-9810的增殖并诱导肿瘤细胞凋亡的作用。

参考文献/References:

[1]De Palma GD,Galloro G,Siciliano S.Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction:results of a prospective,randomized,and controlled study[J].Gastrointest Endosc,2001,53:547-553.
[2]陈颐,王小林,王建华.胆道支架置放结合动脉化疗栓塞治疗恶性梗阻性黄疸[J].复旦学报(医学科学版),2001,28:516.
[3]张福君,吴沛宏,顾仰葵,等.恶性梗阻性黄疸患者内支架植入术后近距离治疗的临床价值[J].癌症,2004,23:1567.
[4]Tanabe K,Serruys PW,Grube E.et al.TAXUSⅢTrial:in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation[J].Circula-tion,2003,107:559-564.
[5]Nakahara C,Nakamura K,Yamanaka N,et al.Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear factor-κB activation in human gastric carcinoma cells[J].Clin Cancer Res,2003,9:5409-5416.
[6]Kindwall-Keller T,Otterson GA,Young D,et al.PhaseⅡevaluation of docetaxel-modulated capecitabine in previously treated patients with non-small cell lung cancer[J].Clin Cancer Res,2005,11:1870-1876.

相似文献/References:

[1]杜学明,许建辉,郎建华,等.多学科技术联合125Ⅰ治疗癌梗阻性黄疸[J].介入放射学杂志,2008,(05):346.
 DU Xueming,XU Jianhui,LANG Jianhua,et al.Combination of multi-disciplinary techniques with125Ⅰseeds in treating malignant obstructive jaundice[J].journal interventional radiology,2008,(01):346.
[2]王彬,闫东,刘德忠,等.胰腺癌不同治疗模式的疗效分析[J].介入放射学杂志,2008,(06):404.
 WANG Bin,YANG Dong,LIU Dezhong,et al.Analysis of different therapeutic programs for patients with pancreatic carcinoma[J].journal interventional radiology,2008,(01):404.
[3]刘德忠,王彬,闫东,等.胰腺癌综合治疗现状及其价值[J].介入放射学杂志,2008,(06):451.
 LIU Dezhong,WANG Bin,YAN Dong,et al.The current status and evaluation of comprehensive therapy of pancreatic carcinoma[J].journal interventional radiology,2008,(01):451.
[4]李槐,刘德忠,闫东.胰腺癌的介入诊疗[J].介入放射学杂志,2008,(06):381.
 LI Huai,LIU Dezhong,YAN Dong.Interventional therapy for pancreatic carcinoma[J].journal interventional radiology,2008,(01):381.
[5]宋恬,殷士蒙,孙荣跃,等.探讨介入治疗对晚期胰腺癌的疗效[J].介入放射学杂志,2008,(06):411.
 SONG Tian,YIN Shimeng,SUN Rongyue,et al.The efficacy discussion of interventional therapy for advanced pancreatic carcinoma[J].journal interventional radiology,2008,(01):411.
[6]王彬,闫东,刘德忠,等.影响胰腺癌疗效的多因素分析[J].介入放射学杂志,2008,(06):414.
 WANG Bin,YAN Dong,LIU Dezhong,et al.Prognostic factors in patients with pancreatic carcinoma[J].journal interventional radiology,2008,(01):414.
[7]陆健,郑云峰,张欢,等.CT导引下植入125I粒子治疗19例晚期胰腺癌的疗效观察[J].介入放射学杂志,2010,(07):550.
 LU Jian,ZHENG Yunfeng,ZHANG Huan,et al.CT-guided radioactive125I-seed implantation for the treatment of pancreatic carcinoma :a clinical observation of 19cases[J].journal interventional radiology,2010,(01):550.
[8]刘卫东,苗善巧,李铁钢,等.胰腺癌介入治疗初步经验[J].介入放射学杂志,1997,(03):182.
[9]张大海.胰周血管的螺旋CT血管造影[J].介入放射学杂志,1998,(03):130.
[10]席名未,谢宗贵,李健,等.经皮穿刺胰管引流及支架置入术在胰腺癌姑息治疗中的应用[J].介入放射学杂志,2007,(05):323.
 XI Ming-wei,XIE Zong-gui,LI Jian,et al.Application of percutaneous pancreatic duct draining and stenting in palliative treatment of pancreatic carcinoma[J].journal interventional radiology,2007,(01):323.

备注/Memo

备注/Memo:
收稿日期:2009-09-25
更新日期/Last Update: 2010-01-15